Two AI‑driven health startups closed seed rounds this week underscoring investor interest in automation across care and discovery. OutcomesAI raised $10 million to commercialize voice‑based AI agents that handle routine patient interactions and reduce nursing workload; the company plans U.S. deployments targeting cost savings in post‑acute and chronic care. Meta‑Flux closed a $2 million seed to scale a multiomics + neural‑network platform that models disease states and predicts therapeutic effects across preclinical biology. Both financings signal continued VC appetite for startups that promise operational efficiencies in care delivery or earlier translational signals in drug discovery.